array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(14) "ELEKTA LIMITED"
["slug"]=>
string(23) "dbe4b-gb-elekta-limited"
["logo"]=>
string(84) "https://images.businessradar.com/linkedin_logos/03cdfb0f-1bfc-426b-afae-aad1f451dee7"
["description"]=>
string(735) "At Elekta, our outcome-driven and cost-efficient solutions provide lasting clinical difference and are developed through sustainable environmental, social and governance practices. We’ve been working openly and proactively with clinicians and our partners for almost half a century to advance precision radiation therapy and meet continuously evolving patient needs—no matter where they are in the world. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in 120 countries and listed on Nasdaq Stockholm. Visit elekta.com to learn more."
["address_street"]=>
string(11) "Linac House"
["address_place"]=>
string(7) "CRAWLEY"
["address_region"]=>
NULL
["founding_date"]=>
string(10) "1996-09-02"
["website_domain"]=>
string(10) "elekta.com"
["website_url"]=>
string(22) "https://www.elekta.com"
["industry_codes"]=>
array(1) {
[0]=>
string(46) "Surgical and Medical Instruments and Apparatus"
}
["employee_count"]=>
int(820)
["article_count"]=>
int(550)
}
["articles"]=>
array(3) {
[0]=>
array(7) {
["title_en"]=>
string(122) "Elekta and the International Atomic Energy Agency (IAEA) Partner to Improve Access to Cancer Care in Underserved Countries"
["snippet_en"]=>
string(181) "August 30, 2023 — Elekta and the IAEAhave signed a partnership agreement to jointly pursue common interests, including making advanced cancer treatment available to more patients."
["url"]=>
string(119) "https://www.itnonline.com/content/elekta-and-international-atomic-energy-agency-iaea-partner-improve-access-cancer-care"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/2fcdc908-07a4-46af-9bcd-f7e39d739424"
["source"]=>
string(13) "itnonline.com"
["publication_date"]=>
string(10) "2023-08-30"
["categories"]=>
array(4) {
[0]=>
string(17) "Energy Management"
[1]=>
string(25) "Business Model Resilience"
[2]=>
string(24) "Access and affordability"
[3]=>
string(13) "Collaboration"
}
}
[1]=>
array(7) {
["title_en"]=>
string(122) "Elekta and the International Atomic Energy Agency (IAEA) partner to improve access to cancer care in underserved countries"
["snippet_en"]=>
string(302) "Elekta (EKTA-B.ST) and the IAEA have signed a partnership agreement to jointly pursue common interests, including making advanced cancer treatment available to more patients. The agreement was signed on Monday, August 28 at Elekta’s headquarters in Stockholm during a three-day visit to Sweden by ..."
["url"]=>
string(171) "https://www.pharmiweb.com/press-release/2023-08-29/elekta-and-the-international-atomic-energy-agency-iaea-partner-to-improve-access-to-cancer-care-in-underserved-countries"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/b8f3950e-6ff1-4e3f-a017-6fb182de79ba"
["source"]=>
string(13) "pharmiweb.com"
["publication_date"]=>
string(10) "2023-08-29"
["categories"]=>
array(4) {
[0]=>
string(17) "Energy Management"
[1]=>
string(25) "Business Model Resilience"
[2]=>
string(24) "Access and affordability"
[3]=>
string(13) "Collaboration"
}
}
[2]=>
array(7) {
["title_en"]=>
string(155) "Elekta / Mitsubishi Electric Collaboration Helps Japan’s Gunma University Heavy Ion Medical Center Launch Advanced Carbon Ion Therapy for Treating Cancer"
["snippet_en"]=>
string(249) "2010-05-16 Patient with prostate carcinoma is center’ s first to benefit from high-energy treatment Three years of teamwork between Elekta and Mitsubishi Electric Corporation came to fruition in March when Gunma University Heavy Ion Medical Center"
["url"]=>
string(217) "https://www.elekta.com/press/e2cd892c-9600-497e-8fd6-7889bc633df5/elekta-mitsubishi-electric-collaboration-helps-japan-s-gunma-university-heavy-ion-medical-center-launch-advanced-carbon-ion-therapy-for-treating-cancer"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/698dd5e1-202f-481a-b41c-0b65b1b5725b"
["source"]=>
string(10) "elekta.com"
["publication_date"]=>
string(10) "2010-05-16"
["categories"]=>
array(3) {
[0]=>
string(17) "Energy Management"
[1]=>
string(17) "Academic Research"
[2]=>
string(13) "Collaboration"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(13) "Collaboration"
["count"]=>
int(35)
}
[1]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(25)
}
[2]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(23)
}
[3]=>
array(2) {
["name"]=>
string(17) "Academic Research"
["count"]=>
int(19)
}
[4]=>
array(2) {
["name"]=>
string(18) "Expansion & Growth"
["count"]=>
int(16)
}
[5]=>
array(2) {
["name"]=>
string(5) "R & D"
["count"]=>
int(16)
}
[6]=>
array(2) {
["name"]=>
string(15) "Market Movement"
["count"]=>
int(15)
}
[7]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(14)
}
[8]=>
array(2) {
["name"]=>
string(5) "Award"
["count"]=>
int(11)
}
[9]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(11)
}
[10]=>
array(2) {
["name"]=>
string(15) "Deals & Tenders"
["count"]=>
int(11)
}
[11]=>
array(2) {
["name"]=>
string(14) "Product Launch"
["count"]=>
int(9)
}
[12]=>
array(2) {
["name"]=>
string(24) "Access and affordability"
["count"]=>
int(8)
}
[13]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(7)
}
[14]=>
array(2) {
["name"]=>
string(25) "Business Model Resilience"
["count"]=>
int(6)
}
[15]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(6)
}
[16]=>
array(2) {
["name"]=>
string(10) "Litigation"
["count"]=>
int(6)
}
[17]=>
array(2) {
["name"]=>
string(12) "Going Public"
["count"]=>
int(6)
}
[18]=>
array(2) {
["name"]=>
string(25) "Leadership and Governance"
["count"]=>
int(5)
}
[19]=>
array(2) {
["name"]=>
string(10) "Executives"
["count"]=>
int(5)
}
[20]=>
array(2) {
["name"]=>
string(5) "Event"
["count"]=>
int(5)
}
[21]=>
array(2) {
["name"]=>
string(21) "Shareholders Feedback"
["count"]=>
int(4)
}
[22]=>
array(2) {
["name"]=>
string(18) "Ecological Impacts"
["count"]=>
int(4)
}
[23]=>
array(2) {
["name"]=>
string(12) "Staff hiring"
["count"]=>
int(4)
}
[24]=>
array(2) {
["name"]=>
string(27) "Business Model & Innovation"
["count"]=>
int(4)
}
[25]=>
array(2) {
["name"]=>
string(17) "Energy Management"
["count"]=>
int(3)
}
[26]=>
array(2) {
["name"]=>
string(20) "Business Development"
["count"]=>
int(3)
}
[27]=>
array(2) {
["name"]=>
string(5) "Legal"
["count"]=>
int(3)
}
[28]=>
array(2) {
["name"]=>
string(20) "Corporate Governance"
["count"]=>
int(2)
}
[29]=>
array(2) {
["name"]=>
string(21) "Intellectual Property"
["count"]=>
int(2)
}
}
}
dbe4b-gb-elekta-limited
ELEKTA LIMITED
Location
Founded
1996-09-02
Website
https://www.elekta.com
Articles
550 Articles
Category
Surgical and Medical Instruments and Apparatus
Description
At Elekta, our outcome-driven and cost-efficient solutions provide lasting clinical difference and are developed through sustainable environmental, social and governance practices. We’ve been working openly and proactively with clinicians and our partners for almost half a century to advance precision radiation therapy and meet continuously evolving patient needs—no matter where they are in the world. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in 120 countries and listed on Nasdaq Stockholm. Visit elekta.com to learn more.
August 30, 2023 — Elekta and the IAEAhave signed a partnership agreement to jointly pursue common interests, including making advanced cancer treatment available to more patients.
Elekta (EKTA-B.ST) and the IAEA have signed a partnership agreement to jointly pursue common interests, including making advanced cancer treatment available to more patients. The agreement was signed on Monday, August 28 at Elekta’s headquarters in Stockholm during a three-day visit to Sweden by ...
2010-05-16 Patient with prostate carcinoma is center’ s first to benefit from high-energy treatment Three years of teamwork between Elekta and Mitsubishi Electric Corporation came to fruition in March when Gunma University Heavy Ion Medical Center
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
